A series of spirocyclic piperidine derivatives were designed and synthesized as σ1 receptor ligands. In vitro competition binding assays showed that 1′-(4-(2-fluoroethoxy) benzyl)-3 H- spiro [2-benzofuran-1, 4′-piperidine](19) possessed high σ1 receptor affinity (K i= 0.79 nM)